Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Clonogenic assays in the B16 melanoma: response to cyclophosphamide

British Journal of Cancer volume 36, pages 618–624 (1977)Cite this article

Abstract

The survival of clonogenic cells in the B16 melanoma has been studied simultaneously by 3 methods: an in vitro assay in soft agar, a lung-colony assay, and the end-point dilution technique. Details of the first 2 methods have previously been reported, but those of the third are described here. The 3 methods have agreed well in investigations of the response of the B16 melanoma to cyclophosphamide.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Authors
  1. G G Steel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T C Stephens
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steel, G., Adams, K. & Stephens, T. Clonogenic assays in the B16 melanoma: response to cyclophosphamide. Br J Cancer 36, 618–624 (1977). https://doi.org/10.1038/bjc.1977.239

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1977.239

This article is cited by

Search

Advanced search

Quick links